The U.S. Food and Drug Administration has expanded the age indication for Nerivio, making it the first and only remote ...

Opioid use disorder (OUD) treatment continued to increase in intervention clinics in the third year of implementation ...

Menopausal hormone therapy (mHT) is not associated with long-term cognitive effects versus placebo, according to a stu ...

FRIDAY, Nov. 22, 2024 (HealthDay News) -- Diagnosis of postpartum depression increased significantly across all racial and ...

Younger and middle-aged patients seem to be disproportionately affected by neurologic manifestations of postacute sequ ...

An estimated 100,429 youth are living with pediatric inflammatory bowel disease (PIBD) in the United States, according ...

It looks like Long COVID takes a bigger toll on younger and middle-aged adults than seniors, a new study finds.Researchers at ...

FRIDAY, Nov. 22, 2024 (HealthDay News) -- Semaglutide and liraglutide are associated with a reduced risk for hospitalization ...

There are considerable differences in life expectancy between different groups within the U.S. population, according t ...

An initial strategy of catheter ablation leads to a lower risk for a composite primary end point than antiarrhythmic d ...

Combination treatment with entinostat and nivolumab results in durable responses in a small subset of patients with ad ...

Recovery from anti-NMDA receptor (anti-NMDAR) encephalitis continues for three years, but deficits persist, according ...